Sign In
Get Clay Free →

Suggestions

    Ayman AlAbdallah

    Venture Capital Investor

    Ayman AlAbdallah is a Partner at Mubadala Capital, based in San Francisco, California.1 He focuses on early and growth-stage investments in healthcare technology, biotechnology, and deep tech companies.2 AlAbdallah joined Mubadala Capital in 2018 as part of the initial team launching the firm's venture capital business in San Francisco.2

    Some key points about Ayman AlAbdallah:

    1. Investment focus: He specializes in the convergence of AI and drug discovery/development, partnering with companies from formation through growth and public rounds.2

    2. Board positions: AlAbdallah serves as a director or observer on the boards of numerous emerging biotechnology companies, including Iambic AI, Juvena Therapeutics, Unlearn AI, Vevo Therapeutics, and Xilis.2

    3. Notable investments: He has backed companies such as Exscientia (EXAI), Neumora (NMRA), Recursion (RXRX), Vir Biotechnology (VIR), and Vividion (acquired by Bayer).2

    4. Professional background: Prior to Mubadala Capital, AlAbdallah's career included roles in corporate development and M&A (Tecan Group), management consulting (Accenture), and hedge fund investing (OMERS Capital).2

    5. Education: He completed his M.B.A. and mechanical engineering studies at the University of Toronto, where he received the Chalmers Award and a fellowship for his engineering research thesis on Lab-on-a-Chip platforms.2

    Regarding Iambic Therapeutics specifically, AlAbdallah led Mubadala Capital's investment in the company's $50 million Series B extension in 2024.3 He expressed enthusiasm for Iambic's AI-driven drug discovery platform and its potential to deliver differentiated drugs to the clinic rapidly.3

    Highlights

    Jul 29 · biopharmadive.com
    How a Mubadala partner views investing in biotech's new normal
    Ayman AlAbdallah - BIO International Convention 2025
    Ayman AlAbdallah - BIO International Convention 2025
    Sep 28 · youtube.com
    Biotech in 2050 w/ Ayman AlAbdallah - Investor @ Mubadala Ventures
    Biotech in 2050 w/ Ayman AlAbdallah - Investor @ Mubadala Ventures

    Related Questions

    What are Ayman AlAbdallah's key investments in the biotech sector?
    How did Ayman AlAbdallah transition from consulting to investing?
    What is Ayman AlAbdallah's role at Mubadala Capital?
    Can you provide examples of Ayman AlAbdallah's most successful investments?
    How does Ayman AlAbdallah contribute to the boards of companies like Iambic Therapeutics?
    Ayman AlAbdallah
    Ayman AlAbdallah, photo 1
    Ayman AlAbdallah, photo 2
    Add to my network

    Location

    San Francisco, California, United States